نتائج البحث 171-180 من 19142 لعملية البحث عن Two-phase
... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development.
The purpose of this study is to determine the maximum tolerated dose (MTD) and schedule and/or a recommended Phase 2 ... Patients will be randomized 1:1 into the ...
The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...
This is a Phase 2 global, multi-center, open-label study to assess the ... two prior lines of therapies. The study has 2 Modules: Module 1 for FL and ...
... phase 2 dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma.
... phase 2 dose (RP2D) of APG-2575. A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies. Rochester, Minn., Jacksonville ...
The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma ...
... phase. A Study to Evaluate EAA181 to Treat Newly-diagnosed Multiple Myeloma ... two prior lines of therapies. The study has 2 Modules: Module 1 for FL and Module ...
In Part 2 Cohort 1, an expansion phase at the established RP2D will be undertaken in participants with selected advanced solid tumors. In Part 2 Cohort 2, a ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.